Literature DB >> 20877107

Comparative study of topical terbinafine and topical ketoconazole in pityriasis versicolor.

V Chopra1, V K Jain.   

Abstract

Fifty patients suffering from pityriasis versicolor were treated with either 2% ketoconazole cream (25 patients) or 1% terbinafine cream (25 patients). Diagnosis was confirmed by microscopic potassium hydroxide (KOH) examination and either of the cream was applied once daily for a duration of 2 weeks. Global assessment was done at the end of treatment with mycological and clinical cure rate of 88% and 96% in ketoconazole and terbinafine treated groups respectively. After a follow up of 3 months the relapse in ketoconazole group was 13.53% and 8.33% in terbinafine group with no side effects.

Entities:  

Year:  2000        PMID: 20877107

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

1.  Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial.

Authors:  Farrokh Rad; Bahram Nik-Khoo; Roxana Yaghmaee; Fardin Gharibi
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

2.  Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial.

Authors:  Somenath Sarkar; Dipayan Sengupta; Sukumar Basak; Shabab Ahmed Damji; Devesh Kumar Shukla; Deep Anurag
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

3.  A Comparative Study of Efficacy and Safety of Eberconazole versus Terbinafine in Patients of Tinea Versicolor.

Authors:  Jyoti Sharma; Jyoti Kaushal; Kamal Aggarwal
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

Review 4.  Antifungal Treatment for Pityriasis Versicolor.

Authors:  Aditya K Gupta; Kelly A Foley
Journal:  J Fungi (Basel)       Date:  2015-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.